Late Onset of Hydrops Fetalis following Intrauterine Parvovirus B19 Infection

Fetal Diagnosis and Therapy

Volumn 12, Issue 1, 1997, Pages 40-42

  Mielk, Gunther ^a   Enders, Gisela ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Institute for Virology   (Germany)

Author keywords

Hydrops fetalis; Intrauterine infection; Parvovirus B19

Indexed keywords

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CASE REPORT; CHROMOSOME ANALYSIS; DYNAMICS; ERYTHEMA INFECTIOSUM; FEMALE; FETUS BLOOD; FETUS HYDROPS; GESTATIONAL AGE; HUMAN; HUMAN CELL; INTRAUTERINE BLOOD TRANSFUSION; INTRAUTERINE INFECTION; MALE; MATERNAL BLOOD; NEWBORN; NONHUMAN; PARVOVIRUS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

EID: 0030981405     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000264424     Document Type: Article

References (12)

1. Public Health Laboratory Service Working Party on Fifth Disease: Prospective study of human parvovirus (BI9) infection in pregnancy. BMJ 1990;300:1166-1170.
2. Schwarz TF, Roggendorf M, Hottentragcr B, Deinhardt F, Endcrs G, Cloning KP, Schramm TH, Hansmann M: Human parvovirus B19 infection in pregnancy. Lancet 1988;2:566-567.
3. Morey AL, Keeling JW, Porter HJ, Fleming KA: Clinical and histopathological features of parvovirus B19 infection in the human fetus. Br J Obstet Gynaecol 1992;99:566-574.
4. Brown KE, Green SW, de Mayolo JA, Bellanti JA, Smith SD, Smith TJ, Young NS: Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994;343:895-896.
5. Smoleniec JS, Pillai M: Management of fetal hydrops associated with parvovirus B19 infection. Br J Obstet Gynaecol 1994; 101:1079-1081.
6. Endcrs G: Infektionen von Mutter, Fetus und Neugeborcnem: Ringclroteln (Parvovirus B19); in Wulf KH, Schmidt-Matthicscn H (eds): Klinik dcr Fraucnheilkunde und Gc-burtshilfe, vol 5: Schwangerschaft II. Miinchen, Urban Schwarzcnberg, 1994, pp 310-313.
7. Fairley CK, Smoleniec JS, Caul OE, Miller E: Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995;346: 1335-1337.
8. Iiessen RG, Van Elsacker-Nicle AMW, Vcr-meij-Keers CHR, Oepkes D. Van Roosmalen J, Gorsira MCB: A fetus with a parvovirus B19 infection and congenital anomalies. Prcnat Diagn 1994;14:173-176.
9. Yaegashi N, Okamura K, Yajima A, Murai C, Sugamura K: The frequency of human parvovirus B19 infection in nonimmune hydrops fetalis. JPcrinat Med 1994:22:159-163.
10. Musiani M, Zerbini M, Gcntilomi G, Plazzi M, Gallinclla G, Vcnuroli S: Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995;172:1360-1363.
11. Carrington D, Whittle MJ, Gibson AAM, Brown T, Field AM, Gilmore DH, Aitken D, Patrick WJA, Caul EO, Clewley JP, Cohen BJ: Maternal serum a-fetoprotein - A marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet 1987;1:433-435.
12. Sailer DN, Rogers BB, Canick JA: Maternal serum biochemical markers in pregnancies with fetal parvovirus B19 infection. Prcnat Diagn 1993;13:467-471.